Jonathan Elsner

Jonathan Elsner, PhD, MBA, currently serves as Vice President of Clinical Operations at Theradaptive, a position held since May 2024. Prior experience includes serving as Vice President of Clinical Affairs at BrioHealth Solutions from August 2023 to April 2024, and at Colospan Ltd from March 2020 to August 2023, where Jonathan established and managed the U.S. clinical operations. Formerly, Jonathan was Vice President of Clinical Affairs at Regentis Biomaterials, overseeing a pivotal IDE multi-center trial for the GelrinC® cartilage regeneration device across 24 sites in the U.S. Additionally, from October 2005 to September 2018, Jonathan held the role of Senior Director, Marketing, Science and Technology at Active Implants, where groundbreaking advancements included the invention of the NUsurface® Meniscus Implant. Jonathan's academic qualifications include a PhD in Biomedical Engineering and an MBA in Entrepreneurship from prestigious institutions.